Search Results 101-110 of 15694 for alt

  1. Tucatinib And Trastuzumab For Patients With HER2-positive Metastatic Colorectal Cancer - Mayo Clinic

    Total bilirubin ≤ 1.5 x upper limit of normal (ULN). Patients with known history of Gilbert Syndrome and total bilirubin < 3 x ULN and normal AST/ALT are ...

  2. Omega-3 Fatty Acids To Combat Sarcopenia - Mayo Clinic

    Chronic active liver disease (Bilirubin > 17mmol/L, AST>144IU/L, or ALT>165IU/L); Anti-coagulant therapy (warfarin/heparin); INR >3; Use of systemic ...

  3. PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes - Mayo Clinic

    ALT (SGPT) < 2 times upper limit of normal; Alkaline phosphatase < 2 times upper limit of normal; Triglycerides < 150 mg/dl (except for Aim 4). Aim 4. Age 30 ...

  4. A Study To Evaluate Rozanolixizumab To Treat Patients With Generalized Myasthenia Gravis - Mayo Clinic

    Bilirubin >1.5xULN (isolated bilirubin >1.5xULN is acceptable if bilirubin is fractionated and direct bilirubin ULN ALT, AST, or ALP that does not meet the ...

  5. Perampanel Transcranial Magnetic Stimulation (TMS) in Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

    Significant laboratory abnormality (AST or ALT >3xULN, or GFR <60); History of aggressive behavior. Subject unwilling to abstain from alcohol for 2 weeks ...

  6. A Phase 1 Study Evaluating The Safety, PK, And Clinical Effects Of PT-112 In Subjects With Advanced Solid Tumors

    AST and ALT are each ≤ 5 × the ULN;; Severe liver dysfunction (Child-Pugh Class B or C) is not present; and; Subjects with a history of esophageal bleeding ...

  7. Iobenguane I-131 Or Crizotinib And Standard Therapy In Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma Or Ganglioneuroblastoma - Mayo Clinic

    ... [ALT]) < 10 x ULN; for the purposes of this study, ULN for SGPT (ALT) is 45 - Shortening fraction of >= 27% by echocardiogram, or ejection fraction of ...

  8. A Phase II, Multicenter Study Of The EZH2 Inhibitor Tazemetostat In Adult Subjects With INI1-Negative Tumors Or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

    If attributed to tumor involvement, AST and ALT <5×ULN. Subjects a history of hepatitis (Exclusion Criterion No. 11) must have ALT within the normal range.

  9. A Study Of Donated Alloantigen Reactive Regulatory T Cells For Reducing Or Discontinuing Immune System Suppression In Liver Transplant Patients - Mayo Clinic

    ALT and either alkaline phosphatase or GGT remain within normal limits or ≤ 1.5 x baseline after darTregs infusion; For subjects with elevated liver tests ...

  10. Testing The Addition Of Total Ablative Therapy To Usual Systemic Therapy Treatment For Limited Metastatic Colorectal Cancer, The ERASur Study - Mayo Clinic

    transaminase [SGOT]) / alanine aminotransferase (ALT)(serum glutamate pyruvate transaminase [SGPT]) =< 3.0 x ULN * In the event of metastatic liver disease ...